Andreas Hoffmann Selected Research

Natriuretic Peptides

8/2009

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Hoffmann Research Topics

Disease

4	Neoplasms (Cancer) 10/2021 - 09/2009
2	Thrombosis (Thrombus) 05/2018 - 01/2015
2	Hemorrhage 05/2018 - 09/2009
2	Heart Valve Diseases (Valvular Heart Disease) 08/2009 - 04/2007
2	Infections 01/2003 - 09/2002
1	Adenocarcinoma 10/2021
1	Asthma (Bronchial Asthma) 01/2019
1	Acute Coronary Syndrome 05/2018
1	Ischemia 05/2018
1	Stable Angina 05/2018
1	Heart Diseases (Heart Disease) 11/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 02/2010
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 02/2010
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 02/2010
1	Esophageal Neoplasms (Esophageal Cancer) 11/2009
1	Ventricular Remodeling 08/2009
1	Atrial Fibrillation 08/2009
1	Mitral Valve Insufficiency (Mitral Regurgitation) 08/2009
1	Peripheral Arterial Occlusive Disease 1 04/2008
1	Heart Failure 04/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2005
1	Endocarditis 01/2005
1	Food Hypersensitivity (Food Allergy) 01/2005
1	Hypersensitivity (Allergy) 01/2005
1	Immediate Hypersensitivity 06/2003
1	Leukemia 06/2003
1	Filariasis 01/2003
1	Burns 09/2002
1	Sepsis (Septicemia) 09/2002
1	Acute-Phase Reaction 09/2002
1	Teratocarcinoma 03/2001

Drug/Important Bio-Agent (IBA)

3	Immunoglobulin E (IgE)IBA 01/2005 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2009
2	AntibodiesIBA 01/2005 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 01/2005 - 03/2001
2	AllergensIBA 01/2005 - 06/2003
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021
1	mepolizumabIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2016
1	Everolimus FDA Link 01/2015
1	silicon carbideIBA 01/2015
1	PolymersIBA 01/2015
1	Prion ProteinsIBA 02/2010
1	RNA (Ribonucleic Acid)IBA 11/2009
1	SurvivinIBA 11/2009
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2009
1	AnticoagulantsIBA 09/2009
1	Warfarin (Coumadin)FDA LinkGeneric 09/2009
1	CreatinineIBA 08/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2009
1	Natriuretic PeptidesIBA 08/2009
1	EpitopesIBA 01/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2005
1	Amino Acids FDA Link 01/2005
1	Immunoglobulin G (IgG)IBA 06/2003
1	Indicators and Reagents (Reagents)IBA 06/2003
1	AntigensIBA 01/2003
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2002
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2002
1	CytokinesIBA 09/2002
1	C-Reactive ProteinIBA 09/2002
1	ProcalcitoninIBA 09/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2002
1	Interleukin-2 (IL2)IBA 09/2002

Therapy/Procedure

4	Cardiac Rehabilitation 11/2015 - 07/2005
2	Stents 05/2018 - 01/2015
1	Therapeutics 01/2019
1	Off-Label Use 01/2019
1	Percutaneous Coronary Intervention 05/2018
1	Secondary Prevention 11/2015
1	Chemoradiotherapy 11/2009
1	Neoadjuvant Therapy 11/2009
1	Immunotherapy 01/2005